PFND — Pathfinder Cell Therapy Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.41m
Annual cashflow statement for Pathfinder Cell Therapy, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2010 December 31st | 2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.29 | -11.3 | -2.16 | -1.71 | -1.39 |
Depreciation | |||||
Non-Cash Items | 0.459 | 8.76 | 0.029 | -0.081 | 0.002 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.01 | 0.163 | 0.083 | 0.174 | 0.426 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -0.833 | -2.33 | -2.02 | -1.6 | -0.963 |
Capital Expenditures | 0 | 0 | 0 | 0 | — |
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.324 | -0.835 | 0 | 0 | — |
Acquisition of Business | |||||
Sale of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.324 | -0.835 | 0 | 0 | — |
Financing Cash Flow Items | 0.307 | 0 | 0 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.16 | 3.35 | 1.84 | 1.64 | 0.945 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.002 | 0.181 | -0.187 | 0.035 | -0.018 |